Literature DB >> 13936148

Biochemical and chromatographic studies of certain activities associated with human fibrinogen preparations.

M W MOSESSON, J S FINLAYSON.   

Abstract

Entities:  

Keywords:  FIBRINOGEN

Mesh：

Substances：

Year:  1963        PMID： 13936148      PMCID： PMC289345          DOI： 10.1172/JCI104767

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  17 in total

1.  A proteolytic inhibitor with anticoagulant activity separated from human urine and plasma.

Authors:  N R SHULMAN
Journal:  J Biol Chem       Date:  1955-04       Impact factor: 5.157

2.  Gelation phenomena in degraded fibrinogen and fibrin.

Authors:  M DERECHIN; S SZUCHET
Journal:  Arch Biochem Biophys       Date:  1960-03       Impact factor: 4.013

3.  The action of proteolytic enzymes on casein proteins.

Authors:  L R CHRISTENSEN
Journal:  Arch Biochem Biophys       Date:  1954-11       Impact factor: 4.013

4.  The fibrin plate method for estimating fibrinolytic activity.

Authors:  T ASTRUP; S MULLERTZ
Journal:  Arch Biochem Biophys       Date:  1952-10       Impact factor: 4.013

5.  Fibrinolytic and proteolytic activity of a human plasminogen, prepared from fraction III of human plasma.

Authors:  E E CLIFFTON; D CANNAMELA
Journal:  J Appl Physiol       Date:  1953-07       Impact factor: 3.531

6.  On the evaluation of the constants Vm and Km in enzyme reactions.

Authors:  G S EADIE
Journal:  Science       Date:  1952-12-19       Impact factor: 47.728

7.  On the evaluation of the constants Vm and KM in enzyme reactions.

Authors:  B H J HOFSTEE
Journal:  Science       Date:  1952-09-26       Impact factor: 47.728

8.  The preparation of human fibrinogen free of plasminogen.

Authors:  M W MOSESSON
Journal:  Biochim Biophys Acta       Date:  1962-02-26

9.  Partial purification and properties of a proteolytic enzyme of human serum.

Authors:  L F REMMERT; P P COHEN
Journal:  J Biol Chem       Date:  1949-11       Impact factor: 5.157

10.  Studies on the inhibition of proteolytic enzymes by serum. I. The mechanism of the inhibition of trypsin, plasmin, and chymotrypsin by serum using fibrin tagged with I131 as a substrate.

Authors:  N R SHULMAN
Journal:  J Exp Med       Date:  1952-06       Impact factor: 14.307
View more
  6 in total

1.  Platelet gene therapy improves hemostatic function for integrin alphaIIbbeta3-deficient dogs.

Authors:  Juan Fang; Eric S Jensen; Mary K Boudreaux; Lily M Du; Troy B Hawkins; Sevasti B Koukouritaki; Kenneth Cornetta; David A Wilcox
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-23       Impact factor: 11.205

2.  Therapeutic expression of the platelet-specific integrin, alphaIIbbeta3, in a murine model for Glanzmann thrombasthenia.

Authors:  Juan Fang; Kairbaan Hodivala-Dilke; Bryon D Johnson; Lily M Du; Richard O Hynes; Gilbert C White; David A Wilcox
Journal:  Blood       Date:  2005-06-21       Impact factor: 22.113

3.  Biophysical investigation of GpIbalpha binding to thrombin anion binding exosite II.

Authors:  T Michael Sabo; Muriel C Maurer
Journal:  Biochemistry       Date:  2009-08-04       Impact factor: 3.162

4.  High fibrinogen γ' levels in patient plasma increase clot formation at arterial and venous shear.

Authors:  Fraser L Macrae; Frauke Swieringa; Johan W M Heemskerk; Robert A S Ariëns
Journal:  Blood Adv       Date:  2021-09-14

5.  Evidence that alpha2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation.

Authors:  M W Mosesson; K R Siebenlist; I Hernandez; K N Lee; V J Christiansen; P A McKee
Journal:  J Thromb Haemost       Date:  2008-06-16       Impact factor: 5.824

6.  The presence of gamma' chain impairs fibrin polymerization.

Authors:  Kathryn C Gersh; Chandrasekaran Nagaswami; John W Weisel; Susan T Lord
Journal:  Thromb Res       Date:  2009-01-12       Impact factor: 3.944
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.